Steven G Terra

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

Current medical research and opinion

Obesity (Silver Spring, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Richard E Pratley, Samuel Dagogo-Jack, Bernard Charbonnel, Shrita Patel, Anne Hickman, Jie Liu, Lisa Tarasenko, Annpey Pong, Misoo C Ellison, Susan Huyck, Ira Gantz, Steven G Terra
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies. Diabetes, obesity & metabolism 22 (12) (2020)
Jie Liu, Lisa Tarasenko, Annpey Pong, Susan Huyck, Shrita Patel, Anne Hickman, James P Mancuso, Misoo C Ellison, Ira Gantz, Steven G Terra
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus. Current medical research and opinion 36 (7) (2020)
Jie Liu, Shrita Patel, Nilo B Cater, Larry Wu, Susan Huyck, Steven G Terra, Anne Hickman, Amanda Darekar, Annpey Pong, Ira Gantz
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism 22 (4) (2020)
Steven B Heymsfield, Annaswamy Raji, Silvina Gallo, Jie Liu, Annpey Pong, Hakima Hannachi, Steven G Terra
Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus. Obesity (Silver Spring, Md.) 28 (4) (2020)
Jie Liu, Lisa Tarasenko, Annpey Pong, Susan Huyck, Larry Wu, Shrita Patel, Anne Hickman, James P Mancuso, Ira Gantz, Steven G Terra
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus. Current medical research and opinion 36 (8) (2020)
Li-Nong Ji, Yanmei Liu, Heng Miao, Yongli Xie, Ming Yang, Wei Wang, Yuting Mu, Ping Yan, Sharon Pan, Brett Lauring, Shu Liu, Susan Huyck, Yanping Qiu, Steven G Terra
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia. Diabetes, obesity & metabolism 21 (6) (2019)
Silvina Gallo, Bernard Charbonnel, Allison Goldman, Harry Shi, Susan Huyck, Amanda Darekar, Brett Lauring, Steven G Terra
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial. Diabetes, obesity & metabolism 21 (4) (2019)
Ronnie Aronson, Juan Pablo Frias, Allison Goldman, Amanda Darekar, Brett Lauring, Steven G Terra
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study. Diabetes, obesity & metabolism 20 (6) (2018)
Richard E Pratley, Roy Eldor, Annaswamy Raji, Gregory Golm, Susan B Huyck, Yanping Qiu, Sheila Sunga, Jeremy Johnson, Steven G Terra, James P Mancuso, Samuel S Engel, Brett Lauring
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial. Diabetes, obesity & metabolism 20 (5) (2018)
Samuel Dagogo-Jack, Jie Liu, Roy Eldor, Guillermo Amorin, Jeremy Johnson, Darcy Hille, Yuqin Liao, Susan Huyck, Gregory Golm, Steven G Terra, James P Mancuso, Samuel S Engel, Brett Lauring
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study. Diabetes, obesity & metabolism 20 (3) (2017)
Steven G Terra, Kristen Focht, Melanie Jane Davies, Juan Frias, Giuseppe Derosa, Amanda Darekar, Gregory Golm, Jeremy Johnson, Didier Saur, Brett Lauring, Sam Dagogo-Jack
Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone. Diabetes, obesity & metabolism 19 (5) (2017)
Julio Rosenstock, Juan Frias, Dénes Páll, Bernard Charbonnel, Raluca Pascu, Didier Saur, Amanda Darekar, Susan Huyck, Harry Shi, Brett Lauring, Steven G Terra
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET). Diabetes, obesity & metabolism 20 (3) (2017)